HUP9800855A2 - Actinobacillus pleuropneumoniae fajhoz tartozó életképes legyengített baktériumok - Google Patents

Actinobacillus pleuropneumoniae fajhoz tartozó életképes legyengített baktériumok

Info

Publication number
HUP9800855A2
HUP9800855A2 HU9800855A HUP9800855A HUP9800855A2 HU P9800855 A2 HUP9800855 A2 HU P9800855A2 HU 9800855 A HU9800855 A HU 9800855A HU P9800855 A HUP9800855 A HU P9800855A HU P9800855 A2 HUP9800855 A2 HU P9800855A2
Authority
HU
Hungary
Prior art keywords
actinobacillus pleuropneumoniae
live attenuated
attenuated bacteria
production
processes suitable
Prior art date
Application number
HU9800855A
Other languages
English (en)
Inventor
Joachim Frey
Ruund Philip Antoon Maria Segers
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of HU9800855D0 publication Critical patent/HU9800855D0/hu
Publication of HUP9800855A2 publication Critical patent/HUP9800855A2/hu
Publication of HUP9800855A3 publication Critical patent/HUP9800855A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A találmány tárgyát Actinőbacillűs pleűrőpneűmőniae nemzetségheztartőzó, egy tőxint kódőló génben műtációt hőrdőzó, életképeslegyengített baktériűmők képezik, valamint a találmány szerintibaktériűmők előállítására alkalmas eljárásők, a baktérimőkattartalmazó őltóanyagők és az őltóanyagők előállítására alkalmaseljárásők. A találmány tárgyát képezik tővábbá tőxint tartalmazó őltóanya-gők, ésaz őltóanyagők előállítására alkalmas eljárásők A találmány szerinti megőldás alkalmas állatők megvédésére,Actinőbacillűs pleűrőpneűmőniai nemzetséghez tartőzó baktériűmőkfertőzése ellen. ŕ
HU9800855A 1997-04-10 1998-04-09 Live attenuated bacteria of the species actinobacillus pleuropneumoniae HUP9800855A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97201032 1997-04-10

Publications (3)

Publication Number Publication Date
HU9800855D0 HU9800855D0 (en) 1998-07-28
HUP9800855A2 true HUP9800855A2 (hu) 1999-03-29
HUP9800855A3 HUP9800855A3 (en) 2004-03-29

Family

ID=8228185

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9800855A HUP9800855A3 (en) 1997-04-10 1998-04-09 Live attenuated bacteria of the species actinobacillus pleuropneumoniae

Country Status (12)

Country Link
US (1) US6013266A (hu)
JP (1) JPH10290695A (hu)
KR (1) KR100510906B1 (hu)
CN (1) CN1198918C (hu)
AU (1) AU743165B2 (hu)
BR (1) BR9801397A (hu)
CA (1) CA2228719A1 (hu)
ES (1) ES2443094T3 (hu)
HU (1) HUP9800855A3 (hu)
NZ (1) NZ330159A (hu)
TW (2) TWI241407B (hu)
ZA (1) ZA982870B (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU769539B2 (en) * 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
GB0228691D0 (en) * 2002-12-09 2003-01-15 Imp College Innovations Ltd Bacterial virulence genes
WO2004078926A2 (en) * 2003-02-28 2004-09-16 Board Of Trustees Operating Michigan State University Immunologigal markers
US8637047B2 (en) * 2003-10-30 2014-01-28 Boehringer Ingelheim Vetmedica, Inc. Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same
AU2010319678A1 (en) * 2009-11-10 2012-05-17 Boehringer Ingelheim Vetmedica, Inc. Actinobacillus suis antigens
ES2416154B1 (es) 2011-11-09 2015-04-01 Laboratorios Hipra, S.A. Cepa viva atenuada de Actinobacillus pleuropneumoniae
KR101491793B1 (ko) 2013-09-10 2015-02-16 대한민국 신규한 액티노바실러스 플로르뉴모니아 혈청형 12번 균주, 이를 포함하는 진단용 조성물 및 백신 조성물
WO2015066292A1 (en) 2013-11-01 2015-05-07 Merial Limited Attenuated pasteurella multocidavaccines & methods of making & use thereof
CN103777018A (zh) * 2014-01-16 2014-05-07 江西农业大学 猪传染性胸膜肺炎放线杆菌快速诊断试纸条的制备方法
GB202011902D0 (en) * 2020-07-30 2020-09-16 Imperial College Innovations Ltd Antinobacillus pleuropneumoniae vaccines
CN112704732B (zh) * 2020-12-24 2022-02-25 华中农业大学 一种猪传染性胸膜肺炎放线杆菌亚单位疫苗

Also Published As

Publication number Publication date
CA2228719A1 (en) 1998-10-10
KR100510906B1 (ko) 2006-01-12
NZ330159A (en) 1998-10-28
BR9801397A (pt) 1999-06-01
CN1202523A (zh) 1998-12-23
TW593678B (en) 2004-06-21
HU9800855D0 (en) 1998-07-28
HUP9800855A3 (en) 2004-03-29
AU743165B2 (en) 2002-01-17
ES2443094T3 (es) 2014-02-17
US6013266A (en) 2000-01-11
CN1198918C (zh) 2005-04-27
ZA982870B (en) 1998-10-09
TWI241407B (en) 2005-10-11
KR19980081220A (ko) 1998-11-25
TW200502384A (en) 2005-01-16
AU6078198A (en) 1998-10-15
JPH10290695A (ja) 1998-11-04

Similar Documents

Publication Publication Date Title
HUP9800855A2 (hu) Actinobacillus pleuropneumoniae fajhoz tartozó életképes legyengített baktériumok
NZ213775A (en) Antibiotic of the vancomycin class and its pure factors; and fermentation preparation from actinomadura sp
DE69733715D1 (de) Antiparasitäre mittel
PT1042340E (pt) Oxima de 6-o-alquil-eritromicina b
KR960700346A (ko) 면역억제제의 제조방법 및 이에 사용되는 신규 미생물(a process for producing immunosuppressives and a novel microbial species to be employed therein)
MY129859A (en) Bacterial strains of the bacterium bacillus thuringiensis and uses therefor
ES484597A1 (es) Metodo de producir antibioticos a partir de organismos del genero pseudomonus.
HUP0204186A2 (hu) Javított eljárás B12 vitamin előállítására
JPS561894A (en) Preparation of antibiotic 3"-n-demethyl-sisomicin
ES8302097A1 (es) Un metodo para producir enduracidina
ATE114710T1 (de) Enzyme aus dem bacillus pabuli zum abbau der zellwand.
BR9807144A (pt) Microorganismos com produção acrescida de ácido clavulânico
ES443463A1 (es) Un procedimiento para la produccion del complejo antibioticobu-2183.
GB1535320A (en) Cultivating of methane-utilizing microorganisms
ES8107303A1 (es) Un metodo para producir antibioticos c-14482 b1, b2 o b3
JPS5585390A (en) Promotion of proliferation of bifidobacterium
JPS55102393A (en) Enzymatic preparation of tyramine
YU47995A (sh) Enzimi mikrobiološkog porekla ftalil amidaza
DK161150C (da) Antibiotikum sb 22484, fremgangsmaade til fremstilling deraf og mikroorganisme til brug ved fremgangsmaaden
JPS5642592A (en) Novel antibiotic and its preparation
AU551023B2 (en) Microorganism and antibiotic therefrom
JPS57186490A (en) Bacterium capable of producing antibiotics y-g665g-a and/or y-g665g-b
JPS5480490A (en) Preparation of l-cysteine and/or l-cystine by fermentation
ES479116A1 (es) Procedimiento para la obtencion de una mezcla de antibioti- cos bm782 alfaii, bm782 alfa 2 y bm782 alfa ia.
UA31153A (uk) Спосіб визначення імунного захисту легень

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: INTERVET INTERNATIONAL B.V., NL

Free format text: FORMER OWNER(S): AKZO NOBEL N.V., NL

FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished